Search research articles
Contact Us
Filters
Showing results (1-10 of 37) with videos related to
Page
of 4
Sort By:
Annals of Translational Medicine
|
February 5, 2020
A TITAN step forward: apalutamide for metastatic castration-sensitive prostate cancer
Daniel Hyuck-Min Kwon, Terence Friedlander
Oncology and Therapy
|
April 7, 2021
Improved Control of Tyrosine Kinase Inhibitor-Induced Diarrhea with a Novel Chloride Channel Modulator: A Case Report
Claire Greene, Brigid Barlesi, Sigrid Tarroza-David, et al.
Clinical Genitourinary Cancer
|
January 9, 2022
Repeat Treatment of Patients With Advanced Urothelial Carcinoma With Immune Checkpoint Inhibitors Following Prior Progression on a Checkpoint Inhibitor Regimen: A Case Series
Tanya Jindal, Jonathan Chou, Terence Friedlander, et al.
Frontiers in Oncology
|
July 25, 2022
Case Report: Clinical Characteristics and Outcomes of HIV Positive Patients With Metastatic Prostate Cancer Treated With Immunotherapy: A Case Series and Literature Review
Dame Idossa, Terence Friedlander, Channing J Paller, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
February 6, 2025
Unmet Potential of Antibody-Drug Conjugates: An Evaluation of the Past, Present, and Future of Antibody-Drug Conjugate Development in Advanced Urothelial Carcinoma
Kevin K Zarrabi, Abhiraj Saxena, Kent W Mouw, et al.
JAMA Oncology
|
October 20, 2017
HSD3B1 and Response to a Nonsteroidal CYP17A1 Inhibitor in Castration-Resistant Prostate Cancer
Nima Almassi, Chad Reichard, Jianbo Li, et al.
The Oncologist
|
March 19, 2017
A Phase I Study of Abiraterone Acetate Combined with BEZ235, a Dual PI3K/mTOR Inhibitor, in Metastatic Castration Resistant Prostate Cancer
Xiao X Wei, Andrew C Hsieh, Won Kim, et al.
Transplantation Direct
|
December 16, 2020
Metastatic Donor-derived Malignancies Following Simultaneous Pancreas-kidney Transplant: Three Case Reports and Management Strategies
Dominic Amara, Steven A Wisel, Hillary J Braun, et al.
JCO Oncology Practice
|
December 21, 2021
Mobile Audio Recording Technology to Promote Informed Decision Making in Advanced Prostate Cancer
Daniel H Kwon, Sneha Karthikeyan, Alison Chang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 17, 2022
A Phase Ib/II Study of the CDK4/6 Inhibitor Ribociclib in Combination with Docetaxel plus Prednisone in Metastatic Castration-Resistant Prostate Cancer
Ivan de Kouchkovsky, Arpit Rao, Benedito A Carneiro, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 37) with videos related to
Sort By:
Page
of 4
Annals of Translational Medicine
|
February 5, 2020
A TITAN step forward: apalutamide for metastatic castration-sensitive prostate cancer
Daniel Hyuck-Min Kwon, Terence Friedlander
Oncology and Therapy
|
April 7, 2021
Improved Control of Tyrosine Kinase Inhibitor-Induced Diarrhea with a Novel Chloride Channel Modulator: A Case Report
Claire Greene, Brigid Barlesi, Sigrid Tarroza-David, et al.
Clinical Genitourinary Cancer
|
January 9, 2022
Repeat Treatment of Patients With Advanced Urothelial Carcinoma With Immune Checkpoint Inhibitors Following Prior Progression on a Checkpoint Inhibitor Regimen: A Case Series
Tanya Jindal, Jonathan Chou, Terence Friedlander, et al.
Frontiers in Oncology
|
July 25, 2022
Case Report: Clinical Characteristics and Outcomes of HIV Positive Patients With Metastatic Prostate Cancer Treated With Immunotherapy: A Case Series and Literature Review
Dame Idossa, Terence Friedlander, Channing J Paller, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
February 6, 2025
Unmet Potential of Antibody-Drug Conjugates: An Evaluation of the Past, Present, and Future of Antibody-Drug Conjugate Development in Advanced Urothelial Carcinoma
Kevin K Zarrabi, Abhiraj Saxena, Kent W Mouw, et al.
JAMA Oncology
|
October 20, 2017
HSD3B1 and Response to a Nonsteroidal CYP17A1 Inhibitor in Castration-Resistant Prostate Cancer
Nima Almassi, Chad Reichard, Jianbo Li, et al.
The Oncologist
|
March 19, 2017
A Phase I Study of Abiraterone Acetate Combined with BEZ235, a Dual PI3K/mTOR Inhibitor, in Metastatic Castration Resistant Prostate Cancer
Xiao X Wei, Andrew C Hsieh, Won Kim, et al.
Transplantation Direct
|
December 16, 2020
Metastatic Donor-derived Malignancies Following Simultaneous Pancreas-kidney Transplant: Three Case Reports and Management Strategies
Dominic Amara, Steven A Wisel, Hillary J Braun, et al.
JCO Oncology Practice
|
December 21, 2021
Mobile Audio Recording Technology to Promote Informed Decision Making in Advanced Prostate Cancer
Daniel H Kwon, Sneha Karthikeyan, Alison Chang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 17, 2022
A Phase Ib/II Study of the CDK4/6 Inhibitor Ribociclib in Combination with Docetaxel plus Prednisone in Metastatic Castration-Resistant Prostate Cancer
Ivan de Kouchkovsky, Arpit Rao, Benedito A Carneiro, et al.
Page
of 4